Parkinson's Disease Trial, Recruiting NCT06241924 Sponsor: University Hospital, Bordeaux Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06241924
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years old
  • Both men and women are eligible
  • People who have Parkinson's disease and have already had surgery to place electrodes in a specific area of the brain (the subthalamic nucleus), connected to a device called PERCEPT™
  • Alternatively, people who have epilepsy that has not responded well to medication and are already undergoing a pre-surgical assessment that involves brain activity monitoring through a method called stereo-EEG
  • People in the epilepsy group who have at least one electrode monitoring a specific deep brain region (the basal ganglia or thalamus)
  • People who are able to perform a simple physical movement task
  • People who are covered by a social security or health insurance scheme
  • People who are willing and able to provide written, informed consent

Who may not be able to join:

  • People who are not able to give their own informed consent
  • People who are under a legal protection order or judicial protection measure
  • People who are pregnant or breastfeeding
  • People who have a serious or currently unstable physical or psychiatric illness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jérôme AUPY, Docteur, University Hospital, Bordeaux

Phone: 05 56 71 43 33

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 February 2024
Est. completion
5 February 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

difference in the cortico-subcortical electrophysiological coherence value

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov